Latest Healthcare Research Reports

Tag: pain management

  • Key Market Drivers, Trends, and Forecast for the Global Facet-Joint Injection Industry

    Key Market Drivers, Trends, and Forecast for the Global Facet-Joint Injection Industry

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Does the Forecast Indicate for the Facet-Joint Injection Market From 2025 to 2029?

    The market size for facet-joint injections has seen robust growth recently. The market is set to expand from $2.78 billion in 2024 to $2.97 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to the growth during the historical period include the surge in chronic back and neck pain cases, increased use of minimally invasive pain treatments, a growing elderly population experiencing spinal deterioration, improved access to image-guided injection procedures, and heightened consciousness about non-surgical pain relief alternatives.

    In the coming years, the market size for facet-joint injections is projected to witness robust growth, set to reach $3.85 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 6.7%. Factors contributing to this growth during the forecast period can be traced back to the surging demand for non-opioid pain management therapies, the increasing implementation of image-guided injection technologies, elevated emphasis on outpatient and day care procedures, growing utilization of regenerative injection treatments and the rise in health care investments in spine disorder remedies. Key trends in the forecast period include progress in ultrasound and fluoroscopy-guided injections, the creation of advanced drug formulations for prolonged pain alleviation, and the development of combined therapies for joint pain, innovative breakthroughs in regenerative therapies including platelet-rich plasma and stem cells, and the evolution in wearable technology for tracking after injection.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24531&type=smp

    What Elements Are Contributing To Growth In The Facet-Joint Injection Market?

    The increase in spinal diseases and chronic back pain cases, due to sedentary lifestyle habits and poor posture, is predicted to accelerate the expansion of the facet-joint injection market. These conditions, which negatively impact the spine over the long term, can lead to continuous pain, hindered movement, and decreased quality of life. Facet-joint injections are being sought out as a minimally disruptive solution that can alleviate pain and restore movement. These injections help manage these conditions by minimizing pain and inflammation in the spine, thus providing relief. As an example, according to Spinal Cord Inc., a US-based non-profit resource center, there were around 18,000 new spinal cord injury (SCI) cases registered annually in the United States in May 2023, with an estimated 302,000 individuals nationwide currently dealing with spinal cord injuries. Subsequently, the escalating incidence of spinal diseases and chronic back pain is contributing to the facet-joint injection market’s growth. The trend for minimally invasive medical procedures is also set to boost the facet-joint injection market’s growth. These procedures, which are often performed through small incisions or without the need for large surgical incisions, are increasingly in demand due to patient preferences for quicker recovery times and less post-operative discomfort. Facet-joint injections contribute to this growing trend, offering targeted pain relief and high diagnostic accuracy without extensive surgical processes. As an example, the American Society of Plastic Surgeons, a US-based specialty organization, reported a rise in minimally invasive cosmetic procedures from 23.7 million in 2022 to 25.4 million in 2023. Consequently, the rising preference for minimally invasive procedures is fundamentally driving the facet-joint injection market’s expansion.

    Which Segments Are Detailed In The Global Facet-Joint Injection Market Report?

    The facet-joint injection market covered in this report is segmented –

    1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types

    2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints, Facet Joint Injections

    3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

    Subsegments:

    1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone, Other Corticosteroids

    2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine, Other Local Anesthetics

    3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid

    4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations, Other Injectables

    Which Emerging Trends And Strategic Shifts Are Shaping The Facet-Joint Injection Market?

    Major corporations in the facet-joint injection market are concentrating their efforts on creating innovative products like facet fusion systems to provide more enduring relief and enhance treatment results. Facet fusion systems are medical devices designed to stabilize and fuse the spine’s facet joints by encouraging bone growth between neighboring vertebrae. For example, the Aurora Spine Corporation, a medical device company based in the US, announced in March 2025 that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance for its latest product, the AEROTM Facet Fusion System. The system employs a titanium plasma spray coating to enhance osseointegration and fusion potential, accommodates various implant sizes to fit different patient anatomies, and has radiolucent instrumentation to boost intraoperative visibility. All of these characteristics work together to enhance the surgical efficiency and long-term results in treating chronic back pain arising from facet joint disorders.

    Who Are The Key Contributors To Growth In The Facet-Joint Injection Market?

    Major companies operating in the facet-joint injection market are Pfizer Inc., Merck & Co. Inc, AbbVie Inc., Sanofi S.A., Medtronic plc, Stryker Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Henry Schein Inc., Bausch Health Companies Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Dr. Reddy’s Laboratories Ltd., Arthrex Inc., Aspen Pharmacare Holdings Limited, Pacira BioSciences Inc., Bioventus Inc., Ferring Pharmaceuticals, Anika Therapeutics Inc., Symbiotec Pharmalab Pvt. Ltd.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/facet-joint-injection-global-market-report

    Which Region Is Projected To Lead The Facet-Joint Injection Market By 2025?

    North America was the largest region in the facet-joint injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24531&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Insights: Lumbosacral Radicular Pain Management Market Expected to Surpass $1.11 Billion by 2029

    Global Insights: Lumbosacral Radicular Pain Management Market Expected to Surpass $1.11 Billion by 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Estimated Industry Valuation for the Lumbosacral Radicular Pain Management Sector?

    The market size for managing lumbosacral radicular pain has seen substantial expansion in the recent past. Anticipated to surge from $0.85 billion in 2024 to $0.9 billion in 2025, it is expected to display a compound annual growth rate (CAGR) of 5.8%. Several factors are responsible for the growth observed in the historical period, including increased incidents of lumbar disc herniation, heightened awareness about spinal disorders, the escalating population of the elderly, advancements in diagnostic imaging methods, and the growing adoption of non-invasive pain management treatments.

    The market size for managing lumbosacral radicular pain is anticipated to experience robust growth over the coming years, ballooning to $1.11 billion by 2029, with a CAGR of 5.5%. This expansion over the forecasted period can be credited to advancements in minimally invasive surgical procedures, growing use of biologic therapies, an increased emphasis on personalized pain management, the escalating demand for outpatient pain clinics, as well as the incorporation of digital health and telemedicine into pain management. Significant trends for the forecast period entail progress in minimally invasive spine surgeries, improvements in neurostimulation devices, the use of biologic therapies such as platelet-rich plasma, AI-guided diagnostics and personalized treatment strategies, coupled with the invention of cutting-edge non-opioid analgesics.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24592&type=smp

    What Forces Are Driving The Growth Of The Lumbosacral Radicular Pain Management Market?

    An increase in cases of back pain disorders is anticipated to boost the lumbosacral radicular pain management market. These disorders of back pain include different conditions that disrupt the functionality of the spine, muscles, or nerves in the back, leading to discomfort or pain. The escalation in these disorders is a result of sedentary lifestyles which leads to weakened back muscles, poor posture, and enduring pain. The goal of lumbosacral radicular pain management is to alleviate irritation of the nerve root in the lower back, thus reducing pain and inflammation, restoring mobility, and enhancing life quality. For example, in June 2024, data from the Australian Institute of Health and Welfare, a government agency in Australia, revealed that in 2022, over half (52%) of all hospital admissions for back issues were due to back or spine pain. In this category, lower back pain held the majority share at 27%, followed by neck pain at 6.2% and radiculopathy at 6.0%. Furthermore, back problems escalated in 2023 to become the third highest contributor to the total health burden, accounting for 4.3%. As a result, the escalating cases of back pain disorders act as a driving force for the growth of the lumbosacral radicular pain management market.

    How Is The Lumbosacral Radicular Pain Management Industry Segmented Across Key Parameters?

    The lumbosacral radicular pain management market covered in this report is segmented –

    1) By Medication: Non-Steroidal Anti-Inflammatory Drugs, Opioids, Antidepressants, Anticonvulsants, Steroids

    2) By Physical Therapy: Manual Therapy, Exercise Therapy, Electrotherapy, Thermal Therapy, Hydrotherapy

    3) By Route Of Administration: Oral, Topical

    4) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Non-Steroidal Anti-Inflammatory Drugs: Ibuprofen, Naproxen, Diclofenac, Celecoxib, Etoricoxib

    2) By Opioids: Tramadol, Oxycodone, Morphine, Hydrocodone, Fentanyl

    3) By Antidepressants: Amitriptyline, Nortriptyline, Duloxetine, Desvenlafaxine, Venlafaxine

    4) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Lamotrigine, Topiramate

    5) By Steroids: Dexamethasone, Methylprednisolone, Prednisone, Triamcinolone, Hydrocortison

    What Notable Trends Are Shaping The Direction Of The Lumbosacral Radicular Pain Management Market?

    Leading businesses in the lumbosacral radicular pain management market are concentrating on the creation of cutting-edge treatments such as investigational oral NaV1.8 pain signal inhibitors, with the aim of providing long-lasting pain relief without the use of opioids. This experimental oral NaV1.8 inhibitor is a medication still in the trial phase, and its main function is to target the NaV1.8 sodium channel, which transmits pain through sensory nerves. For example, in December 2024, the American biotech firm Vertex Pharmaceuticals publicized the results from its Phase 2 trial of Suzetrigine for painful lumbosacral radiculopathy (LSR). The research met its primary aim, demonstrating a clinically relevant and statistically significant decrease in pain from the baseline in those who were given Suzetrigine. Furthermore, Suzetrigine was generally well-received and no severe side effects were noted. Vertex intends to evaluate the efficacy of the drug better in future Phase 3 studies by countering the high placebo response.

    Which Companies Currently Dominate The Competitive Landscape In The Lumbosacral Radicular Pain Management Industry?

    Major companies operating in the lumbosacral radicular pain management market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc, Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Dr Reddy’s Laboratories Ltd, NuVasive Inc., Nobel Biocare Holdings AG, Ultradent Products Inc., Nevro Corp., Zynex Inc., Eliem Therapeutics, Vertebral Technologies Inc., Semnur Pharmaceuticals Inc.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-management-global-market-report

    Which Geographic Regions Are Driving Demand In The Lumbosacral Radicular Pain Management Market?

    North America was the largest region in the lumbosacral radicular pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lumbosacral radicular pain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24592&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Facet-Joint Injection Industry Valued at $3.85 Billion by 2029 With CAGR of 6.7% | Size and Share Insights

    Facet-Joint Injection Industry Valued at $3.85 Billion by 2029 With CAGR of 6.7% | Size and Share Insights

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Facet-Joint Injection Market from 2024 to 2025?

    The market size for facet-joint injections has seen significant growth recently. Projected increases show it going from $2.78 billion in 2024 to $2.97 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to growth in the past include an increase in chronic back and neck pain incidents, a growing preference for minimally invasive pain management treatments, an increasing elderly demographic suffering from spinal degeneration, enhanced availability of image-guided injection procedures, and heightened awareness concerning non-surgical options for pain relief.

    What Is the Projected Market Size of the Facet-Joint Injection Market?

    In the coming years, the market size for facet-joint injections is projected to experience significant growth, reaching a value of $3.85 billion in 2029, with a compound annual growth rate (CAGR) of 6.7%. This predicted growth during the forecast period can be ascribed to factors such as the increasing demand for non-opioid alternatives for pain management, the surge in acceptance of image-guided injection technologies, elevated attention on outpatient and day-care surgical approaches, wider application of regenerative injection therapies, and boosted healthcare investments into therapies for spinal disorders. Key trends projected for the forecast period include the improvement in ultrasound and fluoroscopy-guided injections, the creation of advanced drug formulations for extended pain management, combination therapy developments for joint pain, the invention of innovative regenerative treatments like platelet-rich plasma and stem cells, and progress in wearable technology for monitoring after injections.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24531&type=smp

    Who are the Major Competitors in the Facet-Joint Injection Market Outlook?

    Major companies operating in the facet-joint injection market are Pfizer Inc., Merck & Co. Inc, AbbVie Inc., Sanofi S.A., Medtronic plc, Stryker Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Henry Schein Inc., Bausch Health Companies Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Dr. Reddy’s Laboratories Ltd., Arthrex Inc., Aspen Pharmacare Holdings Limited, Pacira BioSciences Inc., Bioventus Inc., Ferring Pharmaceuticals, Anika Therapeutics Inc., Symbiotec Pharmalab Pvt. Ltd.

    What Is Fueling Growth in the Facet-Joint Injection Market?

    The spike in spinal diseases and chronic back pain instances is set to fuel the expansion of the facet-joint injection market in the future. Spinal diseases and chronic back pain are long-standing conditions affecting the spine, such as arthritis or nerve compression, that result in persistent discomfort, limited mobility, and diminished quality of life. These conditions, triggered by sedentary lifestyles and poor posture habits, have individuals in search of effective treatments that mitigate consistent discomfort and restore functional movement. Facet-joint injections offer a solution for these conditions by lessening the pain and inflammation in the spine. It also provides relief for people enduring the increasing issue of spinal diseases and chronic back pain. For example, Spinal Cord Inc., a non-profit resource center based in the US, reported approximately 18,000 new spinal cord injury cases annually in the United States in May 2023, with an estimated 302,000 individuals nationwide currently suffering from spinal cord injuries. As a result, the facet-joint injection market is seeing growth due to the spike in spinal diseases and chronic back pain. The augmenting demand for minimally invasive procedures is projected to fuel the expansion of the facet-joint injection market. These procedures are medical interventions that are performed through small incisions or without a need for large surgical cuts. The mounting preference amongst patients for quicker recovery periods and less post-operation pain is driving the increase in minimally invasive procedures. Facet-joint injections contribute to the growth of these procedures by offering targeted pain relief and precise diagnosis without the need for major surgical intervention. For instance, according to the American Society of Plastic Surgeons, a specialty organization based in the US, the total number of minimally invasive cosmetic procedures surged from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the facet-joint injection market is seeing growth due to the increasing demand for minimally invasive procedures.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24531&type=smp

    Which Facet-Joint Injection Market Segments Are Growing the Fastest?

    The facet-joint injection market covered in this report is segmented –

    1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types

    2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints, Facet Joint Injections

    3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

    Subsegments:

    1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone, Other Corticosteroids

    2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine, Other Local Anesthetics

    3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid

    4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations, Other Injectables

    Which Industry Trends Are Shaping the Future of the Facet-Joint Injection Market?

    Main players in the industry of facet-joint injection are investing in the development of advanced products, for instance, facet fusion systems, in order to extend the relief duration and boost the results of treatment. Facet fusion systems are a type of medical apparatus created to stabilize and merge the facet joints of the spine, encouraging the growth of bone between adjacent vertebrae. Take for example in March 2025, when Aurora Spine Corporation, a medical device organization based in the United States, reported that their latest product the AEROTM Facet Fusion System, obtained 510(k) clearance from the FDA. The system incorporates a titanium plasma spray coating to enhance osseointegration and increase fusion potential. With a range of implant sizes to suit various patient anatomies, along with radiolucent instrumentation for better visibility during surgery, the system aims to augment procedural efficiency and long-term results for patients dealing with chronic back pain due to facet joint complications.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/facet-joint-injection-global-market-report

    Which Countries Are Leading the Facet-Joint Injection Market?

    North America was the largest region in the facet-joint injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24531

    This Report Delivers Insight On:

    1. How big is the facet-joint injection market, and how is it changing globally?

    2. Who are the major companies in the facet-joint injection market, and how are they performing?

    3. What are the key opportunities and risks in the facet-joint injection market right now?

    4. Which products or customer segments are growing the most in the facet-joint injection market?

    5. What factors are helping or slowing down the growth of the facet-joint injection market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Lumbosacral Radicular Pain Management Industry Growth Expected to Reach $1.11 Billion by 2029 at a CAGR of 5.5% | Segmentation and Growth Opportunities

    Lumbosacral Radicular Pain Management Industry Growth Expected to Reach $1.11 Billion by 2029 at a CAGR of 5.5% | Segmentation and Growth Opportunities

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #What Is the Forecast for the Lumbosacral Radicular Pain Management Market Growth in 2025?#_x000D_

    Recent years have seen substantial growth in the lumbosacral radicular pain management market, with projections showing it expanding from a value of $0.85 billion in 2024 to $0.9 billion in 2025, a compound annual growth rate (CAGR) of 5.8%. The significant growth experienced in the historical period can be traced back to several contributing factors, including a heightened prevalence of lumbar disc herniation, increased consciousness about spinal disorders, a growing number of elderly, advancements in diagnostic imaging technology, and the growing inclination towards non-invasive pain management treatments._x000D_

    _x000D_

    #What Is the Forecast for the Lumbosacral Radicular Pain Management Market Size Through 2029?#_x000D_

    The market size for managing lumbosacral radicular pain is anticipated to undergo substantial growth in the upcoming years, with projections indicating expansion to $1.11 billion by 2029, experiencing a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the forecast period include the introduction of innovative minimally invasive surgical methods, increased usage of biologic therapies, a heightened emphasis on individualized pain management, more demand for outpatient pain clinics, and the incorporation of digital health and telemedicine into pain control strategies. Also, notable trends expected over the forecast period are advancements in minimally invasive procedures for the spine, improvements in neurostimulation devices, adoption of biologic therapies such as platelet-rich plasma, AI-enabled diagnostics and tailored treatment agendas, and the emergence of new non-opioid analgesics._x000D_

    _x000D_

    #Download The Free Sample Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24592&type=smp_x000D_

    _x000D_

    #What are the Key Market Players in Lumbosacral Radicular Pain Management Market and How They’re Evolving?#_x000D_

    Major companies operating in the lumbosacral radicular pain management market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc, Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Dr Reddy’s Laboratories Ltd, NuVasive Inc., Nobel Biocare Holdings AG, Ultradent Products Inc., Nevro Corp., Zynex Inc., Eliem Therapeutics, Vertebral Technologies Inc., Semnur Pharmaceuticals Inc._x000D_

    _x000D_

    #What Are the Primary Growth Drivers in the Lumbosacral Radicular Pain Management Market?#_x000D_

    The escalating occurrence of back pain ailments is anticipated to steer the expansion of the lumbosacral radicular pain management market in the future. Back pain ailments encompass several conditions impacting the spine, muscles, or nerves in the back, leading to discomfort or pain. The escalating occurrence can be ascribed to sedentary lifestyles that lead to weakness in the back muscles, resulting in poor posture and ongoing pain. The goal of lumbosacral radicular pain management is to alleviate nerve root irritation in the lower back, decreasing pain and inflammation. This enhances mobility and life quality. For instance, data from the Australian Institute of Health and Welfare, a government agency based in Australia, reveals that in June 2024, over 52% of all hospitalizations for back issues in 2022 were ascribed to back or spine pain. Lower back pain was responsible for the most significant portion at 27%, succeeded by neck pain at 6.2% and radiculopathy at 6.0%. Furthermore, back issues had escalated to the third leading factor contributing to the overall health burden, representing 4.3% of the total in 2023. Thus, the escalating occurrence of back pain ailments stimulates the expansion of the lumbosacral radicular pain management market._x000D_

    _x000D_

    #Request For A Customized Report:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=24592&type=smp_x000D_

    _x000D_

    #What Are the Leading Segments in the Global Lumbosacral Radicular Pain Management Industry?#_x000D_

    The lumbosacral radicular pain management market covered in this report is segmented –_x000D_

    _x000D_

    1) By Medication: Non-Steroidal Anti-Inflammatory Drugs, Opioids, Antidepressants, Anticonvulsants, Steroids_x000D_

    2) By Physical Therapy: Manual Therapy, Exercise Therapy, Electrotherapy, Thermal Therapy, Hydrotherapy_x000D_

    3) By Route Of Administration: Oral, Topical_x000D_

    4) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Non-Steroidal Anti-Inflammatory Drugs: Ibuprofen, Naproxen, Diclofenac, Celecoxib, Etoricoxib_x000D_

    2) By Opioids: Tramadol, Oxycodone, Morphine, Hydrocodone, Fentanyl_x000D_

    3) By Antidepressants: Amitriptyline, Nortriptyline, Duloxetine, Desvenlafaxine, Venlafaxine_x000D_

    4) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Lamotrigine, Topiramate_x000D_

    5) By Steroids: Dexamethasone, Methylprednisolone, Prednisone, Triamcinolone, Hydrocortison_x000D_

    _x000D_

    #What Are the Key Market Trends in the Lumbosacral Radicular Pain Management Industry?#_x000D_

    Leading organizations in the lumbosacral radicular pain management market are shifting their attention towards the creation of advanced therapeutic options. This includes experimental oral NaV1.8 pain signal inhibitors which act as a non-opioid substitute for enduring pain relief. This investigational oral NaV1.8 pain signal inhibitor is a medication under trial that zeroes in on the NaV1.8 sodium channel, an essential route for the transmission of pain via sensory nerves. For instance, Vertex Pharmaceuticals, a biotech firm based in the US, revealed the outcomes from its Phase 2 study on suzetrigine intended for painful lumbosacral radiculopathy (LSR) in December 2024. The study fulfilled its main goal, exhibiting a statistically significant and clinically relevant decline in pain from the baseline in the suzetrigine group. Suzetrigine was generally well received, with no severe adverse events reported. Vertex intends to tackle the high placebo response in subsequent Phase 3 trials so as to better evaluate the drug’s effectiveness._x000D_

    _x000D_

    #Access The Full Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-management-global-market-report_x000D_

    _x000D_

    #What Is the Regional Outlook for the Lumbosacral Radicular Pain Management Market?#_x000D_

    North America was the largest region in the lumbosacral radicular pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lumbosacral radicular pain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

    _x000D_

    #Purchase The Full Report Today:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24592_x000D_

    _x000D_

    #This Report Delivers Insight On: #_x000D_

    1. How big is the lumbosacral radicular pain management market, and how is it changing globally?_x000D_

    2. Who are the major companies in the lumbosacral radicular pain management market, and how are they performing?_x000D_

    3. What are the key opportunities and risks in the lumbosacral radicular pain management market right now?_x000D_

    4. Which products or customer segments are growing the most in the lumbosacral radicular pain management market?_x000D_

    5. What factors are helping or slowing down the growth of the lumbosacral radicular pain management market?_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 3156230293_x000D_

    Asia +44 2071930708_x000D_

    Europe +44 2071930708_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model